N/A
N=54
Novel Device for Rapid Fluid Administration
Device Related Sepsis
Bottom Line
View on ClinicalTrials.gov: NCT03074682 ↗Enrolled (actual)
54
Serious AEs
—
Results posted
Jan 2019
Primary outcome: Primary: Successful Administration of 60 mL/kg — 14; 18; 16 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Lifeflow (Device); Push/Pull (Device); Pressure Bag (Device)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Yale University
- Primary completion
- Jun 2017
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Successful Administration of 60 mL/kg |
14; 18; 16 | — |
| SECONDARY Time to Complete Fluid Administration |
718.9; 519.4; 376.5 | — |
| SECONDARY NASA Task Load Index (TLX) |
42.50; 40.42; 30.00; 60.00; 57.50; 37.50 | — |
Summary
The aim of the study is to determine if a new device is more effective in fluid administration than devices currently used when resuscitating pediatric patients in septic shock. This study will take place in a simulation lab setting and will not include the use of patients.
Eligibility Criteria
Inclusion Criteria
- Pediatric emergency medicine or pediatric intensive care unit nurses, pediatric residents, medics and attendings.
Exclusion Criteria
- Inability to operate equipment due to illness or physical impairment.
Data sourced from ClinicalTrials.gov (NCT03074682). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.